Heart Valve Replacement Surgery

Understand heart valve replacement — mechanical vs. bioprosthetic valves, surgical vs. minimally invasive approaches, cost comparison, recovery, and how to choose the right program.

Estimated cost: $5,000 – $9,000 · Average stay: 7–9 days

Heart valve replacement is a major cardiac surgical procedure to remove a diseased or non-functioning native heart valve and replace it with a prosthetic substitute — either a mechanical (metallic) valve or a biological (tissue) valve. The human heart has four valves — the aortic, mitral, tricuspid, and pulmonary valves — that function as one-way gates, ensuring blood flows in the correct direction through the heart's chambers with each beat. When a valve becomes severely narrowed (stenosis) or leaks profusely (regurgitation/insufficiency), the heart must work progressively harder to maintain adequate circulation, eventually leading to heart failure if left uncorrected.

Aortic and mitral valve disease account for the vast majority of surgical valve replacements. Aortic stenosis — most commonly caused by calcific degeneration in older adults — is the most prevalent valvular heart disease in the developed world and carries a poor prognosis once symptoms develop without intervention. Mitral regurgitation, most commonly caused by prolapse of the mitral valve leaflets or damage from rheumatic heart disease or myocardial infarction, places a chronic volume overload on the left heart and leads to progressive dilation and dysfunction.

The decision to replace rather than repair a valve depends on the valve anatomy, the severity and mechanism of disease, the patient's age and comorbidities, the surgical center's expertise, and increasingly, the availability of transcatheter valve options. Mitral valve repair — when anatomically feasible — is always preferred over replacement because it preserves the native anatomy, avoids the need for anticoagulation, and provides better long-term left ventricular function. However, when repair is not feasible or durable, replacement remains the definitive solution.

Gaf Healthcare works with high-volume cardiac surgery programs that offer the full range of surgical and transcatheter valve therapies, including robotic-assisted mitral repair, minimally invasive aortic valve replacement, and transcatheter approaches for high-risk patients.

Mechanical vs. Bioprosthetic Valves: Choosing Your Replacement

The most fundamental decision in heart valve replacement is the choice between a mechanical valve and a biological (tissue/bioprosthetic) valve. Each has distinct advantages and drawbacks, and the optimal choice depends on the patient's age, lifestyle, willingness to take lifelong anticoagulation, and preference.

Mechanical valves — constructed from pyrolytic carbon or metallic alloys — are extremely durable, with functional lifespans exceeding 30–40 years and sometimes lasting a lifetime. The critical trade-off is that mechanical valves are inherently thrombogenic (clot-forming), requiring the patient to take a vitamin K antagonist (warfarin) for the rest of their life to prevent stroke. Warfarin requires regular blood monitoring (INR checks) and dose adjustment, imposes dietary restrictions, and carries a small but lifelong risk of major bleeding (approximately 1–2% per year). Mechanical valves are typically recommended for younger patients (under 60–65) who are expected to outlive a tissue valve and who have no contraindication to anticoagulation.

Biological valves — derived from treated bovine pericardium or porcine heart tissue — do not require lifelong anticoagulation after the initial 3-month healing phase; patients typically take only aspirin thereafter. The trade-off is durability: tissue valves in the aortic position last approximately 15–20 years in patients over 65 (longer with improved third-generation designs like the PERIMOUNT Magna Ease and Carpentier-Edwards INSPIRIS), and shorter in younger patients where increased calcium metabolism accelerates structural degeneration. When a tissue valve fails, the patient requires either a redo surgical replacement or a transcatheter valve-in-valve (ViV) procedure. Bioprosthetic valves are typically recommended for older patients (over 65–70) or those with contraindications to anticoagulation.

Who Is a Candidate for Heart Valve Replacement?

The decision to recommend heart valve replacement surgery is based on a combination of the severity of valve dysfunction (assessed by echocardiography), the presence and severity of symptoms, measurements of heart function and size, and the patient's overall surgical risk profile.

For aortic valve replacement, the accepted indications include: severe aortic stenosis with any of the three classical symptoms (angina, syncope, or heart failure/dyspnea); severe symptomatic aortic regurgitation; severe asymptomatic aortic stenosis or regurgitation when echocardiography shows significant left ventricular dilation or impairment (ejection fraction below 50%); and moderate valve disease when patients are undergoing other cardiac surgery (CABG or other valve replacement) and thus the additional risk of addressing both problems is small.

For mitral valve replacement (or repair), indications include: severe symptomatic mitral regurgitation with preserved ventricular function; severe mitral regurgitation with deteriorating ventricular function even if symptoms are not severe; severe symptomatic mitral stenosis when commissurotomy is not feasible; and rheumatic mitral disease causing severe combined stenosis and regurgitation.

Patients are assessed pre-operatively for surgical fitness using the Society of Thoracic Surgeons (STS) score or EuroSCORE II risk calculator. High-risk patients (STS score >8%) may be better served by transcatheter options such as TAVR for the aortic valve or transcatheter edge-to-edge repair (MitraClip/PASCAL) for the mitral valve, rather than open surgery. The complete assessment includes echocardiography, cardiac CT, coronary angiography, pulmonary function tests, and frailty assessment.

How Heart Valve Replacement Is Performed

Surgical heart valve replacement is performed under general anesthesia through a median sternotomy (vertical incision through the breastbone) or, increasingly, through smaller alternative incisions (minimally invasive approaches). The patient is placed on cardiopulmonary bypass; the heart is stopped and protected with cardioplegia solution; and the surgeon opens the relevant cardiac chamber — the aorta for aortic valve surgery, or the left atrium for mitral valve surgery.

The diseased valve is excised; all calcium is carefully removed from the valve annulus (the ring of fibrous tissue the valve sits in) to create a smooth landing zone for the prosthesis. The prosthetic valve is then sized using calibrated sizers, and the correct-size valve is secured in position with multiple pledgeted mattress sutures or continuous sutures depending on the surgeon's technique and the valve design.

For mitral valve repair (preferred over replacement when feasible), the surgeon works to restore the normal geometry and function of the native valve using a combination of leaflet resection, artificial chordal replacement (ePTFE sutures), and annuloplasty ring implantation. The result is confirmed with intraoperative transesophageal echocardiography before closing the heart; a repair with more than mild residual mitral regurgitation or significant gradient typically prompts conversion to replacement.

The average operating time for a single isolated valve replacement is 3–4 hours. Combined procedures (valve replacement plus CABG, or double valve replacement) take correspondingly longer.

Procedure Steps

1. Pre-operative evaluation: transthoracic and transesophageal echocardiography; cardiac catheterisation/CT angiography; surgical risk score (EuroSCORE II/STS); shared decision-making on valve type and approach.
2. Anaesthesia and monitoring: general endotracheal anaesthesia; transoesophageal echocardiography (TOE) probe for intraoperative valve function monitoring; arterial line; central venous catheter.
3. Surgical access: sternotomy (conventional) or right mini-thoracotomy / upper hemisternotomy (minimally invasive approaches).
4. Cardiopulmonary bypass: aortic and venous cannulation; patient placed on bypass; heart arrested with cardioplegia.
5. Valve excision: the relevant chamber opened; native valve leaflets excised; calcium carefully debrided from annulus.
6. Prosthesis sizing and implantation: calibrated sizers confirm annular dimensions; chosen prosthesis sutured into position with pledgeted or continuous sutures.
7. Intraoperative TOE assessment: heart filled and evaluated on TOE before closing — confirming good valve function, no paravalvular leak, preserved ventricular function.
8. Bypass discontinued; haemostasis; chest closure; patient to cardiac ICU for monitoring and recovery.

Types of Heart Valve Replacement Surgery

Conventional Open Valve Replacement (Sternotomy)

The standard approach performed through a full median sternotomy with cardiopulmonary bypass. Provides optimal surgical exposure for complex valve disease, combined procedures (valve + CABG), and re-operative cases. The most widely available approach globally and the technique against which minimally invasive approaches are benchmarked.

Cost: $5,000 – $10,000

Minimally Invasive Valve Surgery (Mini-Sternotomy / Mini-Thoracotomy)

The same valve replacement or repair performed through a smaller incision — a partial upper sternotomy for aortic valve surgery, or a right mini-thoracotomy for mitral valve surgery. Provides equivalent clinical outcomes to conventional surgery with less blood loss, faster sternal healing, shorter ICU and hospital stay, and better cosmesis. Requires specialized surgical training and instrumentation.

Cost: $7,000 – $14,000

Robotic Mitral Valve Repair or Replacement

Uses robotic surgical platforms (da Vinci) to perform mitral valve repair or replacement through four or five small port incisions, without any chest incision. Offers maximal precision for complex mitral valve repairs, the best cosmetic outcome, lowest blood loss, and fastest recovery. Available at specialized robotic cardiac surgery centers with high-volume mitral programs.

Cost: $10,000 – $18,000

Transcatheter Valve Replacement (TAVR / TMVR)

Catheter-based delivery of a prosthetic valve to the aortic (TAVR) or mitral (TMVR) position without open-heart surgery. TAVR is performed through the femoral artery in the groin and is now standard of care for patients with aortic stenosis across all risk categories. TMVR is an emerging technology for mitral valve replacement in patients unsuitable for surgery. No sternotomy, no cardiopulmonary bypass.

Cost: $22,000 – $40,000

Cost Comparison Worldwide

Country — Range — Savings

--- — --- — ---

United States — $60,000 – $200,000 — Baseline

United Kingdom — $18,000 – $35,000 — ~75% vs. USA

Germany — $16,000 – $30,000 — ~80% vs. USA

India — $5,000 – $10,000 — Up to 92% vs. USA

UAE — $15,000 – $28,000 — ~80% vs. USA

Heart valve replacement costs are driven primarily by the type of prosthesis chosen (mechanical valves and advanced tissue valves carry different costs), the surgical approach (minimally invasive and robotic surgery carry higher facility and equipment fees), the length of ICU and hospital stay, and hospital overhead. In the United States, even a straightforward isolated aortic valve replacement under employer-sponsored insurance can generate total bills exceeding $80,000–$120,000 after deductibles and co-insurance.

At internationally accredited programs, the quality of the prosthesis — whether a Medtronic Hancock, Edwards PERIMOUNT, or St. Jude Medical mechanical valve — is identical to what is implanted at US or European centers; prosthetic valves are globally sourced from the same manufacturers. Gaf Healthcare provides transparent, itemized cost estimates that specify the prosthesis type, the surgical approach, and what is included in the hospital stay package.

Recovery & Follow-up

Recovery from heart valve replacement follows the same general trajectory as CABG, with some differences based on the approach used. After conventional sternotomy, sternal protection restrictions (no lifting over 5 kg for 6–8 weeks) are paramount. Patients receiving minimally invasive approaches have significantly faster recovery — often returning to light activity within 2–3 weeks rather than 6–8 weeks.

The most important long-term recovery consideration is anticoagulation management. Patients with mechanical valves require lifelong warfarin, with target INR in the range of 2.5–3.5 depending on the valve position and type. INR monitoring frequency is typically weekly initially, then monthly once stable. Missing anticoagulation doses or allowing the INR to fall below therapeutic range even briefly carries risk of valve thrombosis — a life-threatening emergency. Patients with tissue valves typically take warfarin for only the first 3 months; thereafter, aspirin alone is usually sufficient.

All valve replacement patients receive antibiotic prophylaxis before dental procedures and invasive medical interventions for life to prevent infective endocarditis — a bacterial infection of the prosthetic valve that carries very high morbidity. A medical alert card or bracelet identifying the prosthetic valve type is strongly recommended.

Recovery Tips

• Mechanical valve patients: take warfarin EVERY day at the same time; carry an anticoagulation monitoring card; know the signs of bleeding (unusual bruising, blood in urine/stool, prolonged nosebleed) and seek immediate care.
• Tissue valve patients: anticoagulation for 3 months post-surgery then typically aspirin only — do not stop aspirin without medical advice.
• All patients: always inform every dentist and doctor about your prosthetic heart valve before any procedure — you may need antibiotic prophylaxis to prevent endocarditis.
• Protect the sternal wound: no lifting over 5 kg, no driving for 4–6 weeks after sternotomy; minimally invasive patients usually recover faster.
• Report any unexplained fever above 38°C immediately — it may indicate infective endocarditis, which requires urgent blood cultures and echocardiography.
• Attend all follow-up echocardiograms as scheduled — they monitor valve function and detect early prosthesis problems before they become symptomatic.
• Carry your valve implant card at all times; it lists the valve type, size, and implant date — this is essential information for any emergency medical team.
• Engage in cardiac rehabilitation once cleared — supervised exercise significantly improves heart function and quality of life after valve surgery.

Risks & Complications

Heart valve replacement carries risks similar to CABG in terms of the open-heart surgical platform. Operative mortality for isolated elective aortic valve replacement at experienced centers is approximately 1–3% for low-risk patients; for high-risk or redo surgery, it is higher. Specific risks include stroke (1–3%), deep sternal wound infection (1%), heart block requiring a permanent pacemaker (3–5%), and significant post-operative bleeding requiring re-exploration (2–5%).

Prosthesis-specific long-term risks depend on the valve type. Mechanical valves carry a risk of systemic thromboembolism (stroke) despite adequate anticoagulation (approximately 0.5–1% per patient-year) and a risk of major bleeding from anticoagulation (approximately 1–2% per patient-year). Tissue valves carry the risk of structural valve deterioration — leaflet calcification and tearing — which accelerates in younger patients; when a tissue valve degenerates, the patient faces reoperation or transcatheter valve-in-valve therapy.

Prosthetic valve endocarditis — bacterial infection of the artificial valve — is a rare but devastating complication (0.5–1% per year) that carries 20–40% mortality even with optimal treatment. Rigorous dental hygiene, antibiotic prophylaxis before dental procedures, and prompt treatment of any bacterial infection anywhere in the body are the primary preventive measures.

Why GAF Healthcare

Heart valve replacement requires a program with the full spectrum of capabilities: experienced cardiac surgeons for both repair and replacement techniques, a structural heart disease team for transcatheter alternatives, a specialized cardiac anesthesia team, and a dedicated cardiac ICU with perfusionists experienced in complex valve cases. Gaf Healthcare's partner programs meet these criteria. We facilitate remote digital review of your echocardiography and cardiac catheterization before you travel, so the operative plan — valve type, surgical approach — is determined before you arrive, eliminating uncertainty and enabling precise cost estimation.

Frequently Asked Questions

Should I choose a mechanical or tissue valve?

The general guideline: patients under 60–65 who have no contraindication to anticoagulation typically benefit from a mechanical valve's exceptional durability, avoiding future reoperation. Patients over 65–70 typically prefer a tissue valve to avoid lifelong warfarin, accepting that the valve may need replacing 15–20 years later (often via a transcatheter valve-in-valve procedure). Your choice is made jointly with your cardiac surgeon considering your age, lifestyle, anticoagulation tolerance, access to INR monitoring, and the surgeon's recommendation based on your anatomy.

Can my valve be repaired rather than replaced?

Mitral valve repair is almost always preferred over replacement when the anatomy allows, because it preserves native structure, avoids anticoagulation (for most patients), and provides better long-term ventricular function. Mitral repair feasibility depends on the mechanism of regurgitation — degenerative prolapse is highly repairable (>95% at experienced centers); rheumatic disease often requires replacement. Aortic valve repair is less durable and less widely practiced, though it is appropriate in selected young patients with pure aortic regurgitation.

What is a minimally invasive valve replacement and who qualifies?

Minimally invasive valve surgery performs the same operation through smaller incisions — a right mini-thoracotomy for the mitral valve, or a partial upper sternotomy for the aortic valve. Not all patients are suitable: a CT scan must confirm suitable anatomy and access vessels. The advantages — less bleeding, faster healing, better cosmesis, shorter hospital stay — make it very attractive for appropriate candidates. Most patients under 75 without severe chest deformity or prior thoracic surgery are potentially suitable.

Do I need a pacemaker after valve replacement?

Approximately 3–5% of aortic valve replacement patients require a permanent pacemaker because the sutures near the conduction system can cause heart block — a disruption of the electrical pathway that controls heart rate. This risk is higher with certain valve types and anatomies. In most cases, temporary pacing wires placed during surgery manage any early rhythm issues, and only patients with persistent heart block after several days require a permanent device.

How long will I stay in hospital after valve replacement surgery?

For conventional valve replacement through full sternotomy, the typical hospital stay is 7–9 days: 1–2 days in cardiac ICU, followed by 5–7 days on the cardiac ward for progressive mobilization, anticoagulation stabilization, and confirmation of stable rhythm and wound healing. Minimally invasive approaches typically reduce hospital stay to 4–6 days. We recommend planning to remain locally (near the operating center) for at least 2 weeks after discharge before long-haul travel.

Is it safe to exercise and play sport after valve surgery?

Most patients can return to light-to-moderate exercise (walking, swimming, cycling) within 8–12 weeks and more vigorous exercise within 3–6 months, once cleared by their cardiologist at the post-operative echocardiographic assessment. Contact sports and heavy weightlifting are generally not recommended for patients with mechanical valves on warfarin (bleeding risk from trauma). Your cardiac rehabilitation team will guide a personalised progressive exercise programme.